GTR 111481331
Bids Are Invited For Possible Acquisition Of Medicines To Serve The Municipal Health Fund/Municipal Health Secretariat Of Parintins/Am
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
111481331
Tendering Authority
Subscribe to view
Tender No
009/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For Possible Acquisition Of Medicines To Serve The Municipal Health Fund/Municipal Health Secretariat Of Parintins/Am
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
17-04-2026
Closed
Work Detail
Acebrophylline, Pharmaceutical Form: Syrup; Concentration: 5Mg/Ml; Presentation Form: Bottle With 120Ml., Concentration 50Mg/5Ml, Pharmaceutical Form: Syrup/Adult. Presentation Form: Bottle With 120Ml., Betamethasone Acetate Betamethasone Disodium Phosphate 3Mg/Ml 3Mg/Ml, Presentation Form: Injectable Solution, Acetylcysteine, Dosage: 20 Mg, Ml, Indication: Syrup/Pedriatric. Presentation Form: Bottle With 120Ml., Dosage: 40 Mg, Indication: Syrup/Adult. Presentation Form: Bottle With 120Ml., 04/07/2026 - 12:03:09, Pharmaceutical Form: Injectable Solution; Concentration: 100Mg/Ml; Presentation Form: Ampoule With 3Ml., Acyclovir, Pharmaceutical Form: Tablet; Concentration: 200Mg., Pharmaceutical Form: Cream; Concentration: 50Mg; Presentation Form: 10G Tube, Pharmaceutical Form: Lyophilized Powder For Injectable Solution; Concentration: 250Mg; Presentation Form: Ampoule Bottle, Acetylsalicylic Acid, Pharmaceutical Form: Tablet; Concentration: 100Mg., Ascorbic Acid, Dosage: 100 Mg, Type Of Use: Injectable; Presentation Form: Ampoule With 5Ml., Pharmaceutical Form: Oral Solution; Concentration: 200Mg/Ml; Presentation Form: Bottle With 20Ml., Pharmaceutical Form: Tablet; Concentration: 500Mg., Folic Acid, Pharmaceutical Form: Tablet; Concentration: 5Mg., Pharmaceutical Form: Oral Solution; Concentration: 0.2Mg/Ml., Tranexamic Acid, Pharmaceutical Form: Iv Injectable Solution; Concentration: 50Mg/Ml; Presentation Form: Ampoule With 5Ml., Trichloroacetic Acid, Pharmaceutical Form: Topical Solution; Concentration: 80; Presentation Form: Bottle With 10 Ml., Pharmaceutical Form: Topical Solution; Concentration: 90; Presentation Form: Bottle With 20 Ml, Adenosine, Dosage: 3Mg, Indication: Injectable Solution, Presentation Form: Ampoule With 2Ml., Distilled Water, Presentation Form: Ampoule 10Ml., Presentation Form: Bottle Or Bag With 1000Ml, Packaging Type: In Closed System, Presentation Form: Bottle Or Bag With 500Ml, Albendazole, Pharmaceutical Form: Oral Suspension; Concentration: 40Mg/Ml; Presentation Form: Bottle With 10Ml., Pharmaceutical Form: Tablet; Concentration: 400Mg., Human Albumin, Pharmaceutical Form: Injectable Solution; Concentration: 20; Presentation Form: Ampoule Bottle With 50Ml., Sodium Alendronate, Pharmaceutical Form: Tablet, Concentration: 70Mg., Alteplase, Pharmaceutical Form: Lyophilized Powder For Injectable Solution; Concentration: 50Mg; Presentation Form: Ampoule Bottle, Allopurinol, Pharmaceutical Form: Tablet; Concentration: 300Mg., Ambroxol, Composition: Hydrochloride Salt, Concentration: 15 Mg/5Ml, Pharmaceutical Form: Pediatric Syrup, Presentation Form: Bottle With 120Ml., Concentration: 30 Mg/5Ml, Pharmaceutical Form: Adult Syrup, Amikacin, Pharmaceutical Form: Injectable Solution; Concentration: 50Mg/Ml; Presentation Form: Ampoule With 2Ml, Aminophylline, Pharmaceutical Form: Injectable Solution; Concentration:24Mg/Ml; Presentation Form: Ampoule With 10Ml, Amiodarone (Chloridate), Amiodarone, Pharmaceutical Form: Injectable Solution; Concentration: 150Mg/Ml; Presentation Form: Ampoule With 3Ml., Amoxicillin, Active Ingredient: Associated With Potassium Clavulanate, Pharmaceutical Form: Oral Suspension; Concentration: 250Mg 62.5Mg/5Ml; Presentation Form: Bottle With 75Ml., Pharmaceutical Form: Powder For Oral Suspension; Concentration: 250Mg/5Ml; Presentation Form: Bottle With 150Ml., Pharmaceutical Form: Capsule; Concentration: 500Mg., Ampicillin, Pharmaceutical Form: Lyophilized Powder, C
Key Value
Tender Value
27,681,915 - BRL
Tender Documents
Global Tender Document
a8fac4aa-f6e7-47eb-92cc-1489978bb355.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.